The overall objective of this project is to understand the role of E2F transcription factor in regulation of cell proliferation and how a loss of this regulation can lead to oncogenesis. Indications that the cellular transcription factor E2F plays a role in cell proliferation control was obtained from recent analyses which demonstrated a physical interaction between the tumor suppressor protein Rb and E2F. Further, the loss of Rb function is closely associated with a loss of the Rb-E2F interaction, suggesting that E2F is a functionally relevant target for Rb. Additional proteins involved in cell cycle regulation like p 107, cyclins A and E, and the kinase cdk2 are also found to be associated with E2F, indicating that E2F could be playing a major role in regulating cell proliferation. This project aims at studying the role of E2F in tumorigenesis, differentiation and cell cycle regulation. It will be assessed whether there is correlation between the loss of the Rb-E2F interaction and the generation of a wide variety of human tumors. In addition, the possibility that a mutation of E2F can lead to oncogenesis will be examined. To further understand the mechanism of E2F action, additional proteins that interact with E2F will be identified and cloned. Experiments will also be conducted on the role of E2F and associated proteins in the differentiation process of cells. Finally, attempts will be made to identify the cellular promoters that are targeted by E2F an E2F associated proteins.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA063136-02
Application #
2104799
Study Section
Pathology B Study Section (PTHB)
Project Start
1994-05-01
Project End
1998-02-28
Budget Start
1995-03-01
Budget End
1996-02-29
Support Year
2
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Pathology
Type
Schools of Medicine
DUNS #
167204994
City
New York
State
NY
Country
United States
Zip Code
10032
Rizwani, Wasia; Chellappan, Srikumar P (2015) In vitro replication assay with mammalian cell extracts. Methods Mol Biol 1288:349-62
Rastogi, S; Rizwani, W; Joshi, B et al. (2012) TNF-? response of vascular endothelial and vascular smooth muscle cells involve differential utilization of ASK1 kinase and p73. Cell Death Differ 19:274-83
Pillai, Smitha; Kovacs, Michelle; Chellappan, Srikumar (2010) Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res 70:4931-40
Pillai, Smitha; Dasgupta, Piyali; Chellappan, Srikumar P (2009) Chromatin immunoprecipitation assays: analyzing transcription factor binding and histone modifications in vivo. Methods Mol Biol 523:323-39
Davis, Rebecca; Rizwani, Wasia; Banerjee, Sarmistha et al. (2009) Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One 4:e7524
Pillai, Smitha; Chellappan, Srikumar P (2009) ChIP on chip assays: genome-wide analysis of transcription factor binding and histone modifications. Methods Mol Biol 523:341-66
Rizwani, Wasia; Chellappan, Srikumar P (2009) In vitro replication assay with mammalian cell extracts. Methods Mol Biol 523:203-16
Davis, Rebecca K; Chellappan, Srikumar (2008) Disrupting the Rb-Raf-1 interaction: a potential therapeutic target for cancer. Drug News Perspect 21:331-5
Kinkade, Rebecca; Dasgupta, Piyali; Carie, Adam et al. (2008) A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice. Cancer Res 68:3810-8
Dasgupta, Piyali; Chellappan, Srikumar P (2007) Chromatin immunoprecipitation assays: molecular analysis of chromatin modification and gene regulation. Methods Mol Biol 383:135-52

Showing the most recent 10 out of 29 publications